Cargando…

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus

BACKGROUND: Clinical guidance is needed to initiate, continue, and discontinue drug treatments near the end of life. AIM: To identify drugs and drug classes most often adequate, questionable, or inadequate for older people at the end of life. DESIGN: Delphi consensus survey. SETTING/PARTICIPANTS: Fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morin, Lucas, Laroche, Marie-Laure, Vetrano, Davide L., Fastbom, Johan, Johnell, Kristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132505/ https://www.ncbi.nlm.nih.gov/pubmed/29934849 http://dx.doi.org/10.1007/s00228-018-2507-4

Ejemplares similares

EurOP(2)E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers
por: Bakkum, Michiel J., et al.
Publicado: (2021)

Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany
por: Rausch, Christian, et al.
Publicado: (2020)

The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries
por: Renom-Guiteras, Anna, et al.
Publicado: (2015)

Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study
por: Sundvall, Helena, et al.
Publicado: (2022)

Hospital electronic prescribing system implementation impact on discharge information communication and prescribing errors: a before and after study
por: Mills, Pamela Ruth, et al.
Publicado: (2017)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA)
por: Galvin, Rose, et al.
Publicado: (2014)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study
por: Hedna, Khedidja, et al.
Publicado: (2015)

Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people
por: Moriarty, Frank, et al.
Publicado: (2015)

Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia
por: Venkatason, Padmaa, et al.
Publicado: (2018)

Clinical relevance of potentially inappropriate medications and potential prescribing omissions according to explicit criteria—a validation study
por: Parodi López, Naldy, et al.
Publicado: (2022)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2
por: Farhat, Akram, et al.
Publicado: (2021)

Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study
por: Cadogan, Cathal A., et al.
Publicado: (2021)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients
por: Belfrage, Björn, et al.
Publicado: (2015)

Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study
por: Damoiseaux-Volman, Birgit A., et al.
Publicado: (2020)

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
por: Russo, Leo, et al.
Publicado: (2014)

Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria
por: Cooper, Janine A., et al.
Publicado: (2016)

Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances
por: Gahr, Maximilian, et al.
Publicado: (2021)

Developing confidence in basic prescribing skills during medical school: a longitudinal questionnaire study investigating the effects of a modified clinical pharmacology course
por: Eriksson, Anna L., et al.
Publicado: (2018)

A survey about label enhancement methods for parenteral medication in European hospital pharmacies
por: Larmené-Beld, K. H. M., et al.
Publicado: (2020)

Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study
por: García Rodríguez, Luis A., et al.
Publicado: (2021)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation—a cohort study in primary care
por: Wändell, Per, et al.
Publicado: (2016)

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)
por: Eriksen, Jaran, et al.
Publicado: (2017)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bmdo4rrlm5pvetj5teefqm06jn